. Show Affiliations »
Abstract
Entities: Disease Species
Mesh: See more » AIDS-Related Opportunistic Infections/drug therapyAIDS-Related Opportunistic Infections/epidemiologyAntiviral Agents/adverse effectsAntiviral Agents/therapeutic useComorbidityDrug Therapy, CombinationHIV Infections/drug therapyHIV Infections/epidemiologyHepatitis C, Chronic/drug therapyHepatitis C, Chronic/epidemiologyHumansInterferon alpha-2Interferon-alpha/adverse effectsInterferon-alpha/therapeutic useMulticenter Studies as TopicPolyethylene Glycols/adverse effectsPolyethylene Glycols/therapeutic useRandomized Controlled Trials as TopicRecombinant ProteinsRibavirin/adverse effectsRibavirin/therapeutic useViral Load
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2a
Year: 2004 PMID: 15373058
Source DB: PubMed Journal: MMW Fortschr Med ISSN: 1438-3276